We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+18.02%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$233M
AUM Growth
+$13.5M
Cap. Flow
-$17.7M
Cap. Flow %
-7.58%
Top 10 Hldgs %
50.02%
Holding
78
New
26
Increased
11
Reduced
17
Closed
23

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$8.91M
2
FLR icon
Fluor
FLR
+$8.14M
3
AAP icon
Advance Auto Parts
AAP
+$5.41M
4
SPCE icon
Virgin Galactic
SPCE
+$5.24M
5
BA icon
Boeing
BA
+$4.92M

Sector Composition

Rank Sector Weight
1 Technology 38.69%
2 Industrials 21.2%
3 Communication Services 15.69%
4 Consumer Staples 7.38%
5 Consumer Discretionary 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CISN
76
DELISTED
Cision Ltd. Ordinary Share
CISN
-103,162
Closed -$793K
CARB
77
DELISTED
Carbonite Inc
CARB
-118,220
Closed -$1.83M
CBLK
78
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-219,612
Closed -$5.71M

Similar funds

Clearline Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Clearline Capital held 78 positions worth $233M, up 6.1% from $219M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Clearline Capital withdrew a net $17.7M in Q4 2019, closing 23 positions and reducing 17 holdings. Its most notable exit was Flexion Therapeutics, Inc., an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 43% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Clearline Capital opened a new position in Altria Group worth $9.43M.

  • Clearline Capital's largest Q4 2019 buy was Altria Group: 189,000 shares worth $9.43M.
  • Clearline Capital added most to Paramount Global Class B in Q4 2019, an estimated $4.26M increase.
  • Clearline Capital's biggest Q4 2019 reduction was Cars.com, cutting an estimated $9.55M.
  • Clearline Capital fully exited Flexion Therapeutics, Inc. in Q4 2019, selling an estimated $10.9M.
  • Clearline Capital's ten largest holdings make up 50% of its $233M portfolio in Q4 2019.
  • Clearline Capital opened 26 new positions and closed 23 in Q4 2019.
  • Clearline Capital's portfolio value rose 6.1% quarter-over-quarter to $233M.

Based on Clearline Capital's 13F filing for Q4 2019, filed 14 Feb 2020.